CANF


Company Update (NYSE:CANF): Can Fite Biopharma Ltd (ADR) Reports New Data on CF102’s Liver Protective & Regenerative Properties Published in Scientific Journal

Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) announced the peer reviewed scientific journal Molecular Medicine Report has published an article titled, “A3 adenosine receptor agonist, …

Two Analysts Share Views on What’s in Store for Novavax, Inc. (NVAX) and Can Fite Biopharma Ltd (ADR) (CANF)

Healthcare analysts shed light on vaccine maker Novavax, Inc. (NASDAQ:NVAX), and Israeli biotech firm Can-Fite Biopharma Ltd (NYSE:CANF).

Monday Morning’s Pre-Market Insights: Shake Shack Inc (SHAK), Skyworks Solutions Inc (SWKS), Exelixis, Inc. (EXEL), Can Fite Biopharma Ltd (ADR) (CANF)

Shake Shack Inc (NYSE:SHAK) is up over 6% this morning in pre-market trading following an upgrade from analyst Sharon Zackfia of William Blair. …

Monday Morning’s Market Insights: Apple Inc. (AAPL), Synergy Pharmaceuticals Inc (SGYP), Illumina, Inc. (ILMN), Can Fite Biopharma Ltd (CANF)

Apple Inc. (NASDAQ:AAPL) is up over 1% in pre-market trading after analyst Abhey Lamba of Mizuho Securities upgraded the stock from Neutral to …

Tuesday Morning’s Market Insights: GoPro Inc (GPRO), Exelis, Inc. (EXEL), Can Fite Biopharma Ltd (ADR) (CANF), First Solar, Inc. (FSLR)

GoPro Inc (NASDAQ:GPRO) is up 2.73% in pre-market trading as tech fans prepare for the CES 2016 conference in Las Vegas, set to …

Biotech Beat: Analysts Bullish on Uniqure NV (QURE) and Can Fite Biopharma Ltd (ADR) (CANF)

This week, analysts expressed bullish sentiments on both Uniqure NV (NASDAQ:QURE) and Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) in light of new drug …

Stock Update (NYSEMKT:CANF): Can Fite Biopharma Ltd (ADR) Reports Financial Results for Nine Months Ended September 30, 2015

Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, …

Thursday’s Market Insights: McDonald’s Corporation (MCD), Freeport-McMoRan Inc (FCX), Cempra Inc (CEMP), Can Fite Biopharma Ltd (ADR) (CANF)

McDonald’s Corporation (NYSE:MCD) is up 6.50% in pre-market trading to $109.

Stock Update (NYSE MKT:CANF): U.S. FDA Grants Fast Track Designation to Can-Fite’s CF102 in the Treatment of Liver Cancer

Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts